Dimitrios Xourafas1,2, Timothy M Pawlik2, Jordan M Cloyd3,4. 1. Department of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. 2. Department of Surgery, Wexner Medical Center at The Ohio State University, Columbus, OH, USA. 3. Department of Surgery, Wexner Medical Center at The Ohio State University, Columbus, OH, USA. jordan.cloyd@osumc.edu. 4. Division of Surgical Oncology, The Ohio State University Wexner Medical Center, 410 W 10th Ave, N-907 Doan Hall, Columbus, OH, 43210, USA. jordan.cloyd@osumc.edu.
Abstract
BACKGROUND: While minimally invasive approaches are increasingly being utilized for pancreatoduodenectomy (PD), factors associated with prolonged operative time (OpTime) and hospital length of stay (LOS) remain poorly defined, and it is unclear whether these factors are consistent across surgical approaches. METHODS: The ACS-NSQIP targeted pancreatectomy database from 2014 to 2016 was used to identify all patients who underwent open (OPD), laparoscopic (LPD), or robotic (RPD) pancreatoduodenectomy. Multivariable linear regression analyses were used to evaluate predictors of OpTime and LOS, as well as quantify the changes observed relative to each surgical approach. RESULTS: Among 10,970 patients, PD procedure types varied: 9963 (92%) open, 418 (4%) laparoscopic, and 409 (4%) robotic. LOS was longer for the open and laparoscopic approaches (11 vs. 11 vs. 10 days, P = 0.0068), whereas OpTime was shortest for OPD (366 vs. 426 vs. 435 min, P < 0.0001). Independent predictors of a prolonged OpTime were ASA class ≥ 3 (P = 0.0002), preoperative XRT (P < 0.0001), pancreatic duct < 3 mm (P = 0.0001), T stage ≥ 3 (P = 0.0108), and vascular resection (P < 0.0001) for OPD; T stage ≥ 3 (P = 0.0510) and vascular resection (P = 0.0062) for LPD; and malignancy (P = 0.0460) and conversion to laparotomy (P = 0.0001) for RPD. Independent predictors of increased LOS were age ≥ 65 years (P = 0.0002), ASA class ≥ 3 (P = 0.0012), hypoalbuminemia (P < 0.0001), and preoperative blood transfusion (P < 0.0001) for OPD as well as an OpTime > 370 min (all p < 0.05) and specific postoperative complications (all p < 0.05) for all surgical approaches. CONCLUSIONS: Perioperative risk factors for prolonged OpTime and hospital LOS are relatively consistent across open, laparoscopic, and robotic approaches to PD. Particular attention to these factors may help identify opportunities to improve perioperative quality, enhance patient satisfaction, and ensure an efficient allocation of hospital resources.
BACKGROUND: While minimally invasive approaches are increasingly being utilized for pancreatoduodenectomy (PD), factors associated with prolonged operative time (OpTime) and hospital length of stay (LOS) remain poorly defined, and it is unclear whether these factors are consistent across surgical approaches. METHODS: The ACS-NSQIP targeted pancreatectomy database from 2014 to 2016 was used to identify all patients who underwent open (OPD), laparoscopic (LPD), or robotic (RPD) pancreatoduodenectomy. Multivariable linear regression analyses were used to evaluate predictors of OpTime and LOS, as well as quantify the changes observed relative to each surgical approach. RESULTS: Among 10,970 patients, PD procedure types varied: 9963 (92%) open, 418 (4%) laparoscopic, and 409 (4%) robotic. LOS was longer for the open and laparoscopic approaches (11 vs. 11 vs. 10 days, P = 0.0068), whereas OpTime was shortest for OPD (366 vs. 426 vs. 435 min, P < 0.0001). Independent predictors of a prolonged OpTime were ASA class ≥ 3 (P = 0.0002), preoperative XRT (P < 0.0001), pancreatic duct < 3 mm (P = 0.0001), T stage ≥ 3 (P = 0.0108), and vascular resection (P < 0.0001) for OPD; T stage ≥ 3 (P = 0.0510) and vascular resection (P = 0.0062) for LPD; and malignancy (P = 0.0460) and conversion to laparotomy (P = 0.0001) for RPD. Independent predictors of increased LOS were age ≥ 65 years (P = 0.0002), ASA class ≥ 3 (P = 0.0012), hypoalbuminemia (P < 0.0001), and preoperative blood transfusion (P < 0.0001) for OPD as well as an OpTime > 370 min (all p < 0.05) and specific postoperative complications (all p < 0.05) for all surgical approaches. CONCLUSIONS: Perioperative risk factors for prolonged OpTime and hospital LOS are relatively consistent across open, laparoscopic, and robotic approaches to PD. Particular attention to these factors may help identify opportunities to improve perioperative quality, enhance patient satisfaction, and ensure an efficient allocation of hospital resources.
Authors: Brian J Daley; William Cecil; P Chris Clarke; Joseph B Cofer; Oscar D Guillamondegui Journal: J Am Coll Surg Date: 2015-01-09 Impact factor: 6.113
Authors: Christoph B Egger Halbeis; Richard H Epstein; Alex Macario; Ronald G Pearl; Zvi Grunwald Journal: Anesth Analg Date: 2008-10 Impact factor: 5.108
Authors: Pieter S Stepaniak; Christiaan Heij; Guido H H Mannaerts; Marcel de Quelerij; Guus de Vries Journal: Anesth Analg Date: 2009-10 Impact factor: 5.108
Authors: Sung W Cho; Ching-Wei David Tzeng; W Cory Johnston; Maria A Cassera; Philippa H Newell; Chet W Hammill; Ronald F Wolf; Thomas A Aloia; Paul D Hansen Journal: HPB (Oxford) Date: 2013-09-24 Impact factor: 3.647
Authors: Paul J Speicher; Daniel P Nussbaum; Rebekah R White; Sabino Zani; Paul J Mosca; Dan G Blazer; Bryan M Clary; Theodore N Pappas; Douglas S Tyler; Alexander Perez Journal: Ann Surg Oncol Date: 2014-06-13 Impact factor: 5.344
Authors: Brian M Cusworth; Bradley A Krasnick; Timothy M Nywening; Cheryl A Woolsey; Ryan C Fields; Maria M Doyle; Jingxia Liu; William G Hawkins Journal: HPB (Oxford) Date: 2016-12-08 Impact factor: 3.647
Authors: Marcia Irene Canto; Tossapol Kerdsirichairat; Charles J Yeo; Ralph H Hruban; Eun Ji Shin; Jose Alejandro Almario; Amanda Blackford; Madeline Ford; Alison P Klein; Ammar A Javed; Anne Marie Lennon; Atif Zaheer; Ihab R Kamel; Elliot K Fishman; Richard Burkhart; Jin He; Martin Makary; Matthew J Weiss; Richard D Schulick; Michael G Goggins; Christopher L Wolfgang Journal: J Gastrointest Surg Date: 2019-06-13 Impact factor: 3.452
Authors: Katelyn F Flick; C Max Schmidt; Cameron L Colgate; Michele T Yip-Schneider; Chris M Sublette; Thomas K Maatman; Mazhar Soufi; Eugene P Ceppa; Michael G House; Nicholas J Zyromski; Attila Nakeeb Journal: J Gastrointest Surg Date: 2020-06-24 Impact factor: 3.452
Authors: Christopher G Smith; Daniel L Davenport; Justin Gorski; Anthony McDowell; Brian T Burgess; Tricia I Fredericks; Lauren A Baldwin; Rachel W Miller; Christopher P DeSimone; Charles S Dietrich; Holly H Gallion; Edward J Pavlik; John R van Nagell; Frederick R Ueland Journal: Healthcare (Basel) Date: 2019-07-03